
ã¡ã©ããã³ã®ããã
æ°çºå£²
2020幎6æ23æ¥ïŒç«ïŒã«çºå£²ãããã°ããã®ãã¡ã©ããã³å容äœäœåæ§å
¥ç æ¹åè¬ãã¡ã©ããã«é¡ç²å°å
çš0.2ïŒ
ïŒäžè¬åïŒã¡ã©ããã³ïŒãã®åŠæ¹ç®ãã¯ããããã£ãŠããŸããã
Rp)ãã¡ã©ããã«é¡ç²å°å çš0.2%ã0.5g/ïŒÃå°±å¯å
ïŒïœè¬äŸ¡ã¯ 207.80åãªã®ã§ãä»åã®ïŒæ¥è¬äŸ¡ã¯103.90åãšãªã£ãŠããŸããã¡ã©ããã³å容äœã¢ãŽãã¹ãã®ããŒã¬ã ®ïŒã©ã¡ã«ããªã³ïŒãïŒé 86.2åãªã®ã§ãåçšåºŠã®è¬äŸ¡èšå®ã«ãªã£ãŠããããšæããŸãã
ç²è¬ã¯ç¹ã«èŠã¿ããªããç¡å³ãã§é¡ç²ã¯ãµã©ãµã©ããŠããŸãããç²æ«ç¶ã®ãã®ãæ··ãã£ãŠããããã®ç²æ«ã®åå æ©ãžã®ä»çæ§ã¯å€å°ãã£ãããã«æããŸããã
æ·»ä»ææžæ å ±ãPick Up
ãŸãã¯æè¬èª¬æãããããã«æ·»ä»ææžãã¶ãŒããšçºããæã«æ°ã«ãªã£ãéšåãããã¯ã¢ããããŠã¿ãŸããã
ãçŠå¿ããã«ãããµãã³ãã¬ã€ã³é žå¡©ãæäžäžã®æ£è
ãå¹èœå¹æã6æ³æªæºåã¯16æ³ä»¥äžã®æ£è ã«ãããæå¹æ§åã³å®å šæ§ã¯
確ç«ããŠããªããïŒïŒæ³ïœïŒïŒæ³ã䜿çšã®å¯Ÿè±¡
ãçšæ³åã³çšéã1æ¥1å1mgãå°±å¯åã«çµå£æäžã4mgäžé
ãã»å°±å¯ã®çŽåã«æçšãããããš
ãã»å¢éã«ããã£ãŠã¯ïŒé±é以äžã®ééãããã
ãã»æ¬å€ã¯é£äºãšåæåã¯é£çŽåŸã®æçšã¯é¿ããããš
ããïŒCmaxãäœäžãããããïŒ
ãå¥åº·æäºº6äŸã察象ãšããåœå èšåºè©ŠéšïŒååæäžè©ŠéšïŒã«ãããŠãã¡ã©ããã³1mgãç©ºè ¹æåã¯é£åŸã«ååçµå£æäžãããšããç©ºè ¹æã«æ¯ã¹é£åŸæäžæã®Cmaxã¯15.4ïŒ äœäžããAUC0-10hã¯18.7ïŒ å¢å ããt1/2ã¯11.9ïŒ å¢å ããã
ãçžäºäœçšãæ¬å€ã¯äž»ãšããŠCYP1A2ã«ãã代è¬ãããããã®ä»ãCYP1A1ãCYP1B1åã³CYP2C19ã代è¬ã«é¢äž
ã»ãã«ãããµãã³ãã¬ã€ã³é žå¡©ïŒCYP1A2,2C19ãé»å®³ããŠè¡äžæ¿åºŠäžæïŒCmax1074%,AUC1635%ã«å¢å ïŒïŒïŒå以äžïŒ
ã»ãããã³ç³»æèè¬ïŒã·ããããããµã·ã³ïŒçïŒCYP1A2ãé»å®³ããŠè¡äžæ¿åºŠäžæïŒCmax137%,AUC120%å¢å ïŒ
ã»ã«ãã§ã€ã³ïŒCYP1A2ã®åºè³ªã§ãããã¡ã©ããã³ã®ä»£è¬ãæå¶ããè¡äžæ¿åºŠäžæ
ã»å«ç ïŒCYPïŒA2代è¬é µçŽ èªå°ã§ãã¡ã©ããã³ã®è¡äžæ¿åºŠäœäž
ãè¡äžæ¿åºŠãTmaxïŒ0.21ïœ0.32hrãT1/2ïŒ1.13ïœ2.46hr
ããã€ãªã¢ãã€ã©ããªãã£ã2.5ïœ33%
ãäœçšæ©åºã
ã¡ã©ããã³ã¯èŠäº€åäžæ žã®MT1åã³MT2å容äœã掻æ§åããããšã§èŠäº€åäžæ žã®ç¥çµæŽ»åã調ç¯ããç¡ç ã®èªå°äœçšã瀺ãã
ãåãæ±ãäžã®æ³šæã
ããã«å è£ åãåå ããå Žåã¯ãé®å ããŠä¿åããããšã
æ°ã«ãªãéšåã ãã§ããã¡ããã¡ãã«ãªã£ãŠããŸããŸãããéèŠãªéšåã ããæç²ããŠããŸãã
ãããŸã§ã§ãèªåãèå³ããã£ãã®ã¯ãâ ã¡ã©ããã³ã¯å å æ§ç©è³ªã ãã©ä»çºå£²ã«ãªã£ãã®ã¯ã©ãããŠãïŒâ¡ã«ãã§ã€ã³ãšã¡ã©ããã³ã®çžäºäœçšã£ãŠé¢çœããªâ¢ããŒã¬ã ®ïŒã©ã¡ã«ããªã³ïŒãšåããMT1ãMT2ã«äœçšããè¬ã ãªããšããããšã§ããã
ã¡ã©ããã³çºå£²ãŸã§ã®æµã
ã¡ã©ããã«ã®è£œåæ å ±æŠèŠã®æ å ±ãæç²ãããš
2013幎ãèšåºè©Šéšãéå§
ãâ
2016幎ãç¥çµçºéçã®ãã¡èªéã¹ãã¯ãã©ã çãæããç¡ç é害ã®å°å ã察象ãšããåœå 第⠡/â ¢çžè©ŠéšïŒNPC-15-5詊éšïŒåã³ç¥çµçºéçãæããç¡ç é害ã®å°å ã察象ãšãã26é±éæäžã®åœå 第⠢çžè©ŠéšïŒNPC-15-6詊éšïŒã宿œããæå¹æ§ãšå®å šæ§ãæ€èšŒãããã
ãâ
2019幎1æãæ¥æ¬å°å ç¥çµåŠäŒããåçåŽå倧è£å®ã«ããç¥çµçºéçã«äŒŽãç¡ç é害ã«å¯Ÿããã¡ã©ããã³ã®æ©ææ¿èªãã«ã€ããŠã®èŠææžãæåºããã
ãâ
2019幎4æã補é 販売æ¿èªç³è«ãè¡ã
ãâ
2020幎3æããå°å æã®ç¥çµçºéçã«äŒŽãå ¥ç å°é£ã®æ¹åãã§æ¿èª
å°å åéã§ã¯åŸ æã®è¬ã ã£ããšããããšã§ããã
ã«ãã§ã€ã³ãšã¡ã©ããã³ã®çžäºäœçš
ã«ãã§ã€ã³ããšããšèŠéããŠç ããªããªãããããªãã®ïŒ
ãããæ®éã®ææ³ã§ãã代è¬é µçŽ ã ãã§ã¿ããšãã«ãã§ã€ã³ãšäžç·ã«ãšããšã¡ã©ããã³ã®è¡äžæ¿åºŠã¯äžæããã
Effect of Caffeine Intake 12 or 24 Hours Prior to Melatonin Intake and CYP1A2*1F Polymorphism on CYP1A2 Phenotyping by Melatonin.Basic Clin Pharmacol Toxicol,99(4):300-4,2006
ãã®è³æã®äžã§ã¯ãã¡ã©ããã³æåã®ïŒïŒæéåã®ã«ãã§ã€ã³æåã¯åœ±é¿ãåããªãããïŒïŒæéåã®ã«ãã§ã€ã³æåã¯ã¡ã©ããã³æ¿åºŠãïŒåã«ãããšãããŠããŸããïŒïŒæéã«ãã§ã€ã³ãæã£ãŠããã°ç¢ºå®ã«åœ±é¿ãåããªããšããããšã«ãªããŸãã
ãã ãCYP1A2ã«ã¯éºäŒåã®è¡šçŸåããããã«ãã§ã€ã³ã®ã¡ã©ããã³ä»£è¬æå¶å¹æã¯ãéå«ç è ãš*1F/*1FéºäŒååãæã€äººã§é¡èã§ããããšã瀺ãããŠããè³æããããŸãã
Effects of Caffeine Intake on the Pharmacokinetics of Melatonin, a Probe Drug for CYP1A2 Activity.Br J Clin Pharmacol,56(6):679-82,2003
ããã¿ãŠãããšãã«ãã§ã€ã³ãã¡ã©ããã³ã«åãŒã圱é¿ã¯ãæåæéã«ãã£ãŠãç°ãªã£ãŠãããã人ã«ãã£ãŠãç°ãªã£ãŠãããšèšãããã§ããå¿ ã圱é¿ãåãããšãéããªããšããããšã§ãããã
åŠæ¹ã®ãã£ãã
åŠæ¹ã®ãã£ããã¯ãªãã ã£ãã®ãïŒãä»å話ãããŠãããšãã«ãã¢ã¡ãªã«ã§ã¯ãµããªã¡ã³ããšããŠè²©å£²ãããŠããã®ã«æ¥æ¬ã§ã¯ã©ãããŠãªããã ããïŒãšæã£ãŠãŸããããšããèšèãåºãŠããŸããã
ãããïŒã¡ã©ããã³ã£ãŠæµ·å€ã§ã¯ãµããªã¡ã³ãã§çºå£²ãããŠããã ïŒã
ãšæããŸãããç¥ããŸããã§ããã
詊ãã«åäººèŒžå ¥ãµã€ãã§ã¿ãŠã¿ããš
â ããªãªãµã«å
確ãã«ããããã¡ã©ããã³ã®ãµããªã¡ã³ããåºãŠããŸãããçšéãšããŠã¯ïŒïœïœããã®ãã®ãå€ããããŸãã
â ããè¬ãªã³
ããã§æ€çŽ¢ããŠãããã€ãåºãŠããŸããã
確ãã«ãããŸãã
åŠæ¹ã®ãã£ããã¯ããã®æ£è ããããã®è©±ã ã£ãã®ãããããŸããã
話ãšèª¬æãããŠãé®å è¢ã«å ¥ãããè¬ããæž¡ãããŸãããå ¥ç 广ãä»åŸæ°ã«ãªããšããã§ãã
ã»ããç¡ç è¬ã«ã€ããŠæžããããã°ãããã®ã§ãèå³ãããã°ã¿ãŠã¿ãŠãã ããã


